Endomorphin-2: a biased agonist at the μ-opioid receptor.

Molecular Pharmacology
Guadalupe RiveroEamonn Kelly

Abstract

Previously we correlated the efficacy for G protein activation with that for arrestin recruitment for a number of agonists at the μ-opioid receptor (MOPr) stably expressed in HEK293 cells. We suggested that the endomorphins (endomorphin-1 and -2) might be biased toward arrestin recruitment. In the present study, we investigated this phenomenon in more detail for endomorphin-2, using endogenous MOPr in rat brain as well as MOPr stably expressed in HEK293 cells. For MOPr in neurons in brainstem locus ceruleus slices, the peptide agonists [d-Ala(2),N-Me-Phe(4),Gly(5)-ol]-enkephalin (DAMGO) and endomorphin-2 activated inwardly rectifying K(+) current in a concentration-dependent manner. Analysis of these responses with the operational model of pharmacological agonism confirmed that endomorphin-2 had a much lower operational efficacy for G protein-mediated responses than did DAMGO at native MOPr in mature neurons. However, endomorphin-2 induced faster desensitization of the K(+) current than did DAMGO. In addition, in HEK293 cells stably expressing MOPr, the ability of endomorphin-2 to induce phosphorylation of Ser375 in the COOH terminus of the receptor, to induce association of arrestin with the receptor, and to induce cell surfac...Continue Reading

References

Jul 1, 1985·The Journal of Physiology·R A North, J T Williams
Dec 22, 1983·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·J W Black, P Leff
Nov 20, 1997·The Journal of Biological Chemistry·Y YuJ B Wang
Jun 9, 1998·European Journal of Pharmacology·K HosohataH I Yamamura
Aug 28, 1998·European Journal of Pharmacology·M NaritaL F Tseng
Jan 13, 2006·British Journal of Pharmacology·Alistair D CorbettStewart J Paterson
Apr 14, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Seksiri ArttamangkulJohn T Williams
Oct 30, 2007·Life Sciences·Alexandra TerskiyRichard D Howells
Jan 17, 2008·Molecular Pharmacology·Michael S Virk, John T Williams
Oct 10, 2009·Psychopharmacology·Priyanka A MadiaByron C Yoburn
Mar 2, 2010·The Journal of Biological Chemistry·Paola MolinariTommaso Costa
Sep 3, 2010·Methods in Molecular Biology·Christopher J CauntCraig A McArdle
Oct 30, 2010·The Journal of Pharmacology and Experimental Therapeutics·Terry Kenakin
Mar 25, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Nidia QuillinanJohn T Williams
Mar 26, 2011·British Journal of Pharmacology·Michael M Morgan, MacDonald J Christie
Apr 1, 2011·British Journal of Pharmacology·Christian DollStefan Schulz
May 13, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Vu C DangMacDonald J Christie
May 26, 2011·Molecular Pharmacology·Sudarshan RajagopalRobert J Lefkowitz
Jun 18, 2011·Trends in Pharmacological Sciences·Sudha K Shenoy, Robert J Lefkowitz
Aug 23, 2011·Nature Chemical Biology·Alem W KahsaiRobert J Lefkowitz
Sep 29, 2011·Annual Review of Pharmacology and Toxicology·Eric ReiterRobert J Lefkowitz

❮ Previous
Next ❯

Citations

Feb 27, 2013·Archives of Pharmacal Research·Katarina R Savić VujovićMilica Prostran
Oct 16, 2013·Peptides·Richard J Bodnar
Jul 16, 2013·Trends in Pharmacological Sciences·Rita J ValentinoDebra Bangasser
Jan 17, 2013·Pharmacological Reviews·John T WilliamsMacdonald J Christie
Mar 1, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·William T BirdsongJohn T Williams
Sep 12, 2013·Cellular and Molecular Life Sciences : CMLS·Iness CharfiGraciela Pineyro
Sep 9, 2015·Journal of Chemical Information and Modeling·Paola BisignanoMarta Filizola
May 27, 2015·The Journal of Clinical Investigation·Michael J IadarolaAndrew J Mannes
Jan 30, 2013·Biochemical Society Transactions·Eamonn Kelly
May 20, 2015·European Journal of Pharmacology·Yi Shang, Marta Filizola
Jan 8, 2015·Frontiers in Pharmacology·Stéphane AlloucheNicolas Marie
Oct 9, 2012·Neuron·Mark von Zastrow, John T Williams
Apr 4, 2017·ACS Chemical Neuroscience·Michael RemesicYeon Sun Lee
Mar 25, 2017·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Michael A EmeryShoshana Eitan
Nov 15, 2017·Scientific Reports·Javier BurgueñoJesús Giraldo
Sep 28, 2012·Journal of Biomolecular Screening·Alisa KnapmanMark Connor
May 8, 2013·British Journal of Pharmacology·E Kelly
Mar 29, 2014·British Journal of Pharmacology·T A MaceyS L Ingram
Apr 5, 2014·British Journal of Pharmacology·A E CookeE Kelly
May 23, 2014·British Journal of Pharmacology·Alisa KnapmanMark Connor
May 28, 2015·Molecular Pharmacology·Georgina L ThompsonMeritxell Canals
Jan 1, 2016·Journal of Neurochemistry·Sumita ChakrabartiAlan R Gintzler
Sep 10, 2019·British Journal of Pharmacology·Rob HillGraeme Henderson
Feb 14, 2020·British Journal of Pharmacology·Andrea KliewerStefan Schulz
Mar 22, 2020·Molecular Pharmacology·William T Birdsong, John T Williams
Sep 27, 2018·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Rita J Valentino, Nora D Volkow
Jun 9, 2019·Molecular Pharmacology·Alexandra E Conibear, Eamonn Kelly
May 13, 2020·Proceedings of the National Academy of Sciences of the United States of America·Ivone GomesLakshmi A Devi
Mar 20, 2014·British Journal of Pharmacology·Graeme Henderson
Jun 7, 2020·International Journal of Molecular Sciences·Xiao ZhangEric J Vallender
Feb 18, 2014·British Journal of Pharmacology·Alisa Knapman, Mark Connor
Oct 16, 2019·Proceedings of the National Academy of Sciences of the United States of America·Zoltan DekanMacDonald J Christie

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.